Abstract:Background: Rather than a passive reflection of nociception, pain is shaped by the interplay between one's experiences, current cognitive-affective states, and expectations. The placebo response, a paradoxical yet reliable phenomenon, is postulated to reduce pain by engaging mechanisms shared with active therapies. It has been assumed that mindfulness meditation, practiced by sustaining nonjudgmental awareness of arising sensory events, merely reflects mechanisms evoked by placebo. Recently, brain-based multivariate pattern analysis has been validated to successfully disentangle nociceptive-specific, negative affective, and placebo-based dimensions of the subjective pain experience. Methods: To determine whether mindfulness meditation engages distinct brain mechanisms from placebo and sham mindfulness to reduce pain, multivariate pattern analysis pain signatures were applied across 2 randomized clinical trials that employed overlapping psychophysical pain testing procedures (49 °C noxious heat; visual analog pain scales) and distinct functional magnetic resonance imaging techniques (blood oxygen level-dependent; perfusion based). After baseline pain testing, 115 healthy participants were randomized into a 4-session mindfulness meditation (n = 37), placebo-cream conditioning (n = 19), sham mindfulness meditation (n = 20), or book-listening control (n = 39) intervention. After each intervention, noxious heat was administered during functional magnetic resonance imaging and each manipulation. Results: A double dissociation in the multivariate pattern analysis signatures supporting pain regulation was revealed by mindfulness meditation compared with placebo cream. Mindfulness meditation produced significantly greater reductions in pain intensity and pain unpleasantness ratings and nociceptive-specific and negative affective pain signatures than placebo cream, sham mindfulness meditation, and control interventions. The placebo-cream group significantly lowered the placebo-based signature. Conclusions: Mindfulness meditation and placebo engaged distinct and granular neural pain signatures to reduce pain.

Brain and body: Implanting a placebo in the brain to alleviate pain

How do placebos ease pain? Mouse brain study offers clues

Neural circuit basis of placebo pain relief

Enhancing Excitatory Activity of Somatosensory Cortex Alleviates Neuropathic Pain Through Regulating Homeostatic Plasticity

Correction: Divergent Modulation of Pain and Anxiety by GABAergic Neurons in the Ventrolateral Periaqueductal Gray and Dorsal Raphe.

Impaired Feedforward Inhibition Of Corticopontine Neurons Drives Placebo Analgesia

Reverse engineering placebo analgesia

Placebo effect involves unexpected brain regions

Placebos and painkillers: is mind as real as matter?

Neural mechanisms underlying placebo and nocebo effects in tonic muscle pain

A novel investigation of placebo analgesia through social communication in mice

Placebo treatment affects brain systems related to affective and cognitive processes, but not nociceptive pain

A prototype closed-loop brain–machine interface for the study and treatment of pain

Frontal-Brainstem Pathways Mediating Placebo Effects on Social Rejection

A new animal model of placebo analgesia: involvement of the dopaminergic system in reward learning

Closed-loop stimulation using a multiregion brain-machine interface has analgesic effects in rodents

Placebo Effects and the Molecular Biological Components Involved

Failure of Placebo Analgesia Model in Rats with Inflammatory Pain.

Mindfulness Meditation and Placebo Modulate Distinct Multivariate Neural Signatures to Reduce Pain

Neuropsychological mechanisms of observational learning in human placebo effects

A Synthetic Peptide Exerts Nontolerance-Forming Antihyperalgesic and Antidepressant Effects in Mice